Clinical trial
An Exploratory Study to Evaluate the Safety and Efficacy of a Novel Transcatheter Pulmonary Thrombectomy System Which Named 'TwiFlow' for Acute Pulmonary Embolism
NCT05443919 is registered in ClinicalTrials.gov with Morningside (Nantong) Medical Co.,Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Exploratory Study to Evaluate the Safety and Efficacy of a Novel Transcatheter Pulmonary Thrombectomy System Which Named 'TwiFlow' for Acute Pulmonary Embolism
- Lead sponsor
- Morningside (Nantong) Medical Co.,Ltd
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 1, 2022
- Completion date
- January 10, 2023
- Enrollment
- 13 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.